PHARMACOLOGY BASIC PRINCIPLES

Anti-Tumour Necrosis Factor Therapy: 2 weeks to response; may eventually lose response despite higher doses due to development of ab to infliximab Action: dysregulation of TH1 response present, in which TNF-α involved – it binds to cell surface ................
................